Clinical trial
a Feasibility Study of Accelerated Hypofractionated Radiotherapy in Node Positive Breast Cancer Patients Treated With Surgery
NCT04792346 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- a Feasibility Study of Accelerated Hypofractionated Radiotherapy in Node Positive Breast Cancer Patients Treated With Surgery
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- March 2, 2021
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer